↓ Skip to main content

Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and Diseases

Overview of attention for article published in Frontiers in immunology, January 2021
Altmetric Badge

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and Diseases
Published in
Frontiers in immunology, January 2021
DOI 10.3389/fimmu.2020.621774
Pubmed ID
Authors

Pau Serra, Pere Santamaria

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 13%
Student > Bachelor 4 13%
Student > Master 3 10%
Researcher 2 7%
Other 2 7%
Other 1 3%
Unknown 14 47%
Readers by discipline Count As %
Medicine and Dentistry 4 13%
Pharmacology, Toxicology and Pharmaceutical Science 3 10%
Biochemistry, Genetics and Molecular Biology 3 10%
Immunology and Microbiology 3 10%
Unspecified 1 3%
Other 1 3%
Unknown 15 50%